Mark S. Schroeder - Mar 7, 2024 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Stock symbol
LH
Transactions as of
Mar 7, 2024
Transactions value $
-$854,622
Form type
4
Date filed
3/11/2024, 08:59 AM
Previous filing
Feb 13, 2024
Next filing
Mar 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise $248K +2.12K +26.6% $117.09 10.1K Mar 7, 2024 Direct
transaction LH Common Stock Sale -$1.1M -5.05K -50.06% $218.45 5.04K Mar 7, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Non-qualified Stock Options Options Exercise $0 -2.12K -100% $0.00* 0 Mar 7, 2024 Common Stock 2.12K $117.09 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F3 Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.
F4 The option vested in three equal annual installments beginning on the date reflected in this column.